ID   STK3_RAT                Reviewed;         491 AA.
AC   O54748;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   24-JUL-2024, entry version 168.
DE   RecName: Full=Serine/threonine-protein kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Mammalian STE20-like protein kinase 2;
DE            Short=MST-2;
DE   AltName: Full=STE20-like kinase MST2;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 3 36kDa subunit;
DE              Short=MST2/N;
DE   Contains:
DE     RecName: Full=Serine/threonine-protein kinase 3 20kDa subunit;
DE              Short=MST2/C;
GN   Name=Stk3; Synonyms=Mst2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Thyroid;
RX   PubMed=9430685; DOI=10.1074/jbc.273.3.1477;
RA   Aurisicchio L., Dilauro R., Zannini M.;
RT   "Identification of the thyroid transcription factor 1 as a target for rat
RT   MST2 kinase.";
RL   J. Biol. Chem. 273:1477-1482(1998).
RN   [2]
RP   ACTIVITY REGULATION, AND PHOSPHORYLATION AT THR-180.
RX   PubMed=12554736; DOI=10.1074/jbc.m211085200;
RA   Deng Y., Pang A., Wang J.H.;
RT   "Regulation of mammalian STE20-like kinase 2 (MST2) by protein
RT   phosphorylation/dephosphorylation and proteolysis.";
RL   J. Biol. Chem. 278:11760-11767(2003).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Stress-activated, pro-apoptotic kinase which, following
CC       caspase-cleavage, enters the nucleus and induces chromatin condensation
CC       followed by internucleosomal DNA fragmentation. Key component of the
CC       Hippo signaling pathway which plays a pivotal role in organ size
CC       control and tumor suppression by restricting proliferation and
CC       promoting apoptosis. The core of this pathway is composed of a kinase
CC       cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory
CC       protein SAV1, phosphorylates and activates LATS1/2 in complex with its
CC       regulatory protein MOB1, which in turn phosphorylates and inactivates
CC       YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2
CC       inhibits its translocation into the nucleus to regulate cellular genes
CC       important for cell proliferation, cell death, and cell migration.
CC       STK3/MST2 and STK4/MST1 are required to repress proliferation of mature
CC       hepatocytes, to prevent activation of facultative adult liver stem
CC       cells (oval cells), and to inhibit tumor formation (By similarity).
CC       Phosphorylates NKX2-1. Phosphorylates NEK2 and plays a role in
CC       centrosome disjunction by regulating the localization of NEK2 to
CC       centrosomes, and its ability to phosphorylate CROCC and CEP250. In
CC       conjunction with SAV1, activates the transcriptional activity of ESR1
CC       through the modulation of its phosphorylation. Positively regulates
CC       RAF1 activation via suppression of the inhibitory phosphorylation of
CC       RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates
CC       MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38
CC       (By similarity). {ECO:0000250|UniProtKB:Q13188,
CC       ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:9430685}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q13188};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000250|UniProtKB:Q13188};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q13188};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000250|UniProtKB:Q13188};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q13188};
CC   -!- ACTIVITY REGULATION: Inhibited by the C-terminal non-catalytic region.
CC       Activated by caspase-cleavage. Full activation also requires
CC       homodimerization and autophosphorylation of Thr-180, which are
CC       inhibited by the proto-oncogene product RAF1. Activated by RASSF1 which
CC       acts by preventing its dephosphorylation. When autophosphorylated at
CC       Thr-180, recruits STRIPAK complex and promotes PP2A-mediated
CC       dephosphorylation and inactivation of STK3.
CC       {ECO:0000250|UniProtKB:Q13188}.
CC   -!- SUBUNIT: Homodimer; mediated via the coiled-coil region. Interacts with
CC       NORE1, which inhibits autoactivation (By similarity). Interacts with
CC       and stabilizes SAV1. Interacts with RAF1, which prevents dimerization
CC       and phosphorylation. Interacts with RASSF1. Interacts (via SARAH
CC       domain) with isoform 1 of NEK2. Interacts with ESR1 only in the
CC       presence of SAV1. Interacts with PKB/AKT1. Forms a tripartite complex
CC       with MOBKL1B and STK38. Interacts with RASSF2 (via SARAH domain).
CC       Interacts with DLG5 (via PDZ domain 3). Interacts with LATS1; this
CC       interaction is inhibited in the presence of DLG5. Interacts with MARK3
CC       in the presence of DLG5. Interacts with RASSF5; this interaction
CC       inhibits STK3 autoactivation through heterodimerization. Interacts
CC       (when phosphorylated) with SLMAP (via FHA domain); the interaction
CC       associates STK3 with the STRIPAK complex (By similarity).
CC       {ECO:0000250|UniProtKB:Q13043, ECO:0000250|UniProtKB:Q13188}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13188}. Nucleus
CC       {ECO:0000250|UniProtKB:Q13188}. Note=The caspase-cleaved form cycles
CC       between nucleus and cytoplasm (By similarity). Phosphorylation at Thr-
CC       117 leads to inhibition of nuclear translocation (By similarity).
CC       {ECO:0000250|UniProtKB:Q13188}.
CC   -!- PTM: Autophosphorylated on two residues Thr-174 and Thr-180, leading to
CC       activation. Phosphorylation at Thr-117 and Thr-384 by PKB/AKT1, leads
CC       to inhibition of its: cleavage, kinase activity, autophosphorylation at
CC       Thr-180, binding to RASSF1 and nuclear translocation, and increase in
CC       its binding to RAF1. Phosphorylated at Ser-15 by PLK1, leading to
CC       activation. {ECO:0000250|UniProtKB:Q13188}.
CC   -!- PTM: Proteolytically cleaved by caspase-3 during apoptosis. Proteolytic
CC       cleavage results in kinase activation and nuclear translocation of the
CC       truncated form (MST1/N) (By similarity).
CC       {ECO:0000250|UniProtKB:Q13188}.
CC   -!- PTM: Ubiquitinated by TRIM69; leading to its redistribution to the
CC       perinuclear cytoskeleton. {ECO:0000250|UniProtKB:Q13188}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001529; CAA04814.1; -; mRNA.
DR   RefSeq; NP_113923.1; NM_031735.1.
DR   AlphaFoldDB; O54748; -.
DR   SMR; O54748; -.
DR   IntAct; O54748; 1.
DR   MINT; O54748; -.
DR   STRING; 10116.ENSRNOP00000062778; -.
DR   ChEMBL; CHEMBL5169099; -.
DR   iPTMnet; O54748; -.
DR   PhosphoSitePlus; O54748; -.
DR   PaxDb; 10116-ENSRNOP00000062778; -.
DR   GeneID; 65189; -.
DR   KEGG; rno:65189; -.
DR   UCSC; RGD:68412; rat.
DR   AGR; RGD:68412; -.
DR   CTD; 6788; -.
DR   RGD; 68412; Stk3.
DR   eggNOG; KOG0574; Eukaryota.
DR   InParanoid; O54748; -.
DR   OrthoDB; 152877at2759; -.
DR   PhylomeDB; O54748; -.
DR   Reactome; R-RNO-2028269; Signaling by Hippo.
DR   PRO; PR:O54748; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0060706; P:cell differentiation involved in embryonic placenta development; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0003157; P:endocardium development; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0035329; P:hippo signaling; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0046621; P:negative regulation of organ growth; ISO:RGD.
DR   GO; GO:0001841; P:neural tube formation; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0060215; P:primitive hemopoiesis; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0071539; P:protein localization to centrosome; ISO:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   GO; GO:0060800; P:regulation of cell differentiation involved in embryonic placenta development; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   CDD; cd21888; SARAH_MST2; 1.
DR   CDD; cd06612; STKc_MST1_2; 1.
DR   Gene3D; 1.10.287.4270; -; 1.
DR   Gene3D; 4.10.170.10; p53-like tetramerisation domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024205; Mst1_2_SARAH_domain.
DR   InterPro; IPR049568; Mst2_SARAH.
DR   InterPro; IPR036674; p53_tetramer_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011524; SARAH_dom.
DR   InterPro; IPR050285; STE20_Ser/Thr_kinase.
DR   PANTHER; PTHR48015; SERINE/THREONINE-PROTEIN KINASE TAO; 1.
DR   PANTHER; PTHR48015:SF23; SERINE_THREONINE-PROTEIN KINASE 3; 1.
DR   Pfam; PF11629; Mst1_SARAH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50951; SARAH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Coiled coil; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..491
FT                   /note="Serine/threonine-protein kinase 3"
FT                   /id="PRO_0000247764"
FT   CHAIN           1..322
FT                   /note="Serine/threonine-protein kinase 3 36kDa subunit"
FT                   /id="PRO_0000413717"
FT   CHAIN           323..491
FT                   /note="Serine/threonine-protein kinase 3 20kDa subunit"
FT                   /id="PRO_0000413718"
FT   DOMAIN          27..278
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          437..484
FT                   /note="SARAH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00310"
FT   REGION          301..343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          370..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          291..324
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        327..343
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33..41
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         56
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         151
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   BINDING         164
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   SITE            322..323
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         117
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         180
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12554736"
FT   MOD_RES         316
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         378
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         384
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13188"
SQ   SEQUENCE   491 AA;  56122 MW;  90FA6B020E7FFD62 CRC64;
     MEQPPAPKSK LKKLSEDSLT KQPEEVFDVL EKLGEGSYGS VFKAIHKESG QVVAIKQVPV
     ESDVQEIIKE ISIMQQCDSP YVVKYYGSYF KNTDLWIVME YCGAGSVSDI IRLRNKTLTE
     DEIATILKST LKGLEYLHFM RKIHRDIKAG NILLNTEGHA KLADFGVAGQ LTDTMAKRNT
     VIGTPFWMAP EVIQEIGYNC VADIWSLGIT SIEMAEGKPP YADIHPMRAI FMIPTNPPPT
     FRKPELWSDD FTDFVKKCLV KSPEQRATAT QLLQHPFIKN AKPVSILREL ITEGMEIKAK
     RHEEQQRELE DEEENSDEDE LDSHTMVKTS SEGVGTMRAT STMSEGAQTM IEHNSTMLES
     DLGTMVINSE DEEEEDGTMK RNATSPQVQR PSFMDYFDKQ DFKNKSHENC DQSMREPCPM
     SNNVFPDNWR VPQDGDFDFL KNLSLEELQM RLKALDPMME REIEELHQRY SAKRQPILDA
     MDAKKRRQQN F
//
